Stock Events

Stock Events

Celldex Therapeutics (CLDX) Q3 2024 Earnings

8AugConfirmed

Q4 2023

Q1 2024

Q2 2024

Q3 2024

-0.83

-0.73

-0.64

-0.54

Details

Expected EPS

-0.587778

Actual EPS

-0.54

Surprise EPS

0.05

Surprise Percent

+8.13%

Description

Celldex Therapeutics (CLDX) has reported earnings of -0.54 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.